Constitutively active JAK2-STAT5 signaling has been shown to be associated with increased surface PD-L1 expression due to amplified PD-L1 promoter activity in myeloproliferative neoplasms, which may facilitate PD-L1-mediated immune escape[63,64]. This evidence concerns the gene JAK2 and myeloproliferative disorder.